Abstract: The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.
Type:
Grant
Filed:
March 30, 2000
Date of Patent:
November 12, 2002
Assignee:
Baxter International
Inventors:
James E. Kipp, Mark J. Doty, Christine L. Rebbeck, Jan Y. Eilert